In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Imagine asking a search engine platform questions about your health and getting responses based on your own DNA. That's ...
In the phase 1 portion of the trial, two doses of gedatolisib were administered IV on an intermittent schedule (Days 1, 8, 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback